Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 215

IsoPlexis applies itself to IPO filing

Yale University is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

Jul 23, 2021

Couchbase sits pretty in $200m IPO

Docomo Capital-backed database software provider Couchbase floated above its range in an offering following some $250m in venture funding.

Jul 23, 2021

ArcelorMittal helps Form Energy recharge in $200m round

ArcelorMittal led the rechargeable battery developer's series D round with a $25m investment through its XCarb vehicle.

Jul 23, 2021

FloQast counts on Coupa in $110m round

Coupa’s recently launched venture capital fund has contributed to a series D round for FloQast that valued the accounting software provider at $1.2bn.

Jul 23, 2021

Sundae sucks in $80m

First American Financial invested in the repossession real estate marketplace through a series C round increasing its overall funding to more than $132m.

Jul 23, 2021

Daily Deal Round Up: July 22, 2021

Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

Jul 22, 2021

SmartRecruiters secures $110m in series E funding

The Salesforce-backed recruitment managemeent software provider was valued at $1.5bn in a round that pushed its overall funding past $200m.

Jul 22, 2021

TMRW taps GV for $105m series C

TMRW Life Sciences is eyeing a global expansion of its frozen egg and embryo management services with new capital from investors including GV.

Jul 22, 2021

OpenSea captures $100m at $1.5bn valuation

The NFT marketplace, which counts Coinbase, Animoca Brands and Gumi as investors, raised the funding in a series B round led by Andreessen Horowitz.

Jul 22, 2021

IsoPlexis applies itself to IPO filing

Danaher is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

Jul 22, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here